​

Coya Therapeutics (COYA) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChart

COYA Stock Forecast

Coya Therapeutics (COYA) stock forecast, based on 5 Wall Street analysts, predicts a 12-month average price target of $18.00, with a high of $18.00 and a low of $18.00. This represents a 171.90% increase from the last price of $6.62.

$5 $8 $11 $14 $17 $20 High: $18 Avg: $18 Low: $18 Last Closed Price: $6.62

COYA Stock Rating

Coya Therapeutics stock's rating consensus is Buy, based on 5 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 5 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 5 0 5 Strong Sell Sell Hold Buy Strong Buy

COYA Price Target Upside V Benchmarks

TypeNameUpside
StockCoya Therapeutics171.90%
SectorHealthcare Stocks 18.80%
IndustryBiotech Stocks 54.28%

Price Target Trends

1M3M12M
# Anlaysts--1
Avg Price Target--$18.00
Last Closing Price$6.62$6.62$6.62
Upside/Downside--171.90%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jul, 2515---6
Jun, 2514---5
May, 2514---5
Apr, 2514---5
Mar, 2514---5
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Sep 16, 2024Raghuram SelvarajuH.C. Wainwright$18.00$6.12194.12%171.90%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Sep 16, 2024H.C. WainwrightBuyinitialise
Jun 12, 2024Rodman & RenshawBuyinitialise
Jun 08, 2023Chardan CapitalBuyBuyhold

Financial Forecast

EPS Forecast

$-1K $-800 $-600 $-400 $-200 $0 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-0.79$-976.50----
Avg Forecast$-0.87$-1.10$-1.26$-1.30$-0.56$-0.19
High Forecast$-0.31$-1.08$-1.08$-1.29$-0.20$-0.07
Low Forecast$-1.30$-1.11$-1.44$-1.31$-0.83$-0.28
Surprise %-9.20%88672.73%----

Revenue Forecast

$0 $800M $2B $2B $3B $4B Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$6.00M$3.55B----
Avg Forecast$4.05M$3.67M$6.30M$10.00M$15.00M$25.00M
High Forecast$5.57M$3.74M$8.02M$13.75M$20.63M$34.38M
Low Forecast$2.02M$3.59M$4.58M$5.00M$7.50M$12.50M
Surprise %48.20%96811.32%----

Net Income Forecast

$-15B $-12B $-9B $-6B $-3B $0 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-7.99M$-14.88B----
Avg Forecast$-7.99M$-11.13M$-12.79M$-13.21M$-5.23M$-1.93M
High Forecast$-3.11M$-10.94M$-10.96M$-13.11M$-1.99M$-675.90K
Low Forecast$-13.22M$-11.32M$-14.61M$-13.31M$-8.47M$-2.87M
Surprise %-133606.80%----

COYA Forecast FAQ

Is Coya Therapeutics stock a buy?

Coya Therapeutics stock has a consensus rating of Buy, based on 5 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 5 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Coya Therapeutics is a favorable investment for most analysts.

What is Coya Therapeutics's price target?

Coya Therapeutics's price target, set by 5 Wall Street analysts, averages $18 over the next 12 months. The price target range spans from $18 at the low end to $18 at the high end, suggesting a potential 171.90% change from the previous closing price of $6.62.

How does Coya Therapeutics stock forecast compare to its benchmarks?

Coya Therapeutics's stock forecast shows a 171.90% upside, outperforming the average forecast for the healthcare stocks sector (18.80%) and outperforming the biotech stocks industry (54.28%).

What is the breakdown of analyst ratings for Coya Therapeutics over the past three months?

  • July 2025: 16.67% Strong Buy, 83.33% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • June 2025: 20.00% Strong Buy, 80.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • May 2025: 20.00% Strong Buy, 80.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Coya Therapeutics’s EPS forecast?

Coya Therapeutics's average annual EPS forecast for its fiscal year ending in December 2025 is $-1.26, marking a -99.87% decrease from the reported $-976 in 2024. Estimates for the following years are $-1.3 in 2026, $-0.56 in 2027, and $-0.19 in 2028.

What is Coya Therapeutics’s revenue forecast?

Coya Therapeutics's average annual revenue forecast for its fiscal year ending in December 2025 is $6.3M, reflecting a -99.82% decrease from the reported $3.55B in 2024. The forecast for 2026 is $10M, followed by $15M for 2027, and $25M for 2028.

What is Coya Therapeutics’s net income forecast?

Coya Therapeutics's net income forecast for the fiscal year ending in December 2025 stands at $-12.786M, representing a -99.91% decrease from the reported $-14.881B in 2024. Projections indicate $-13.213M in 2026, $-5.229M in 2027, and $-1.931M in 2028.